Skip to main content
. 2012 May 25;4(2):319–323. doi: 10.3892/ol.2012.734

Table III.

Antibodies to AEG-1 detected at the time of diagnosis in different stage patients.

Sample AEG-1-Abs positive case n (%) in stage I and II AEG-1-Abs positive case n (%) in stage III and IV P-value
Breast cancer 9 (30) 35 (51) 0.049
Hepatic carcinoma 8 (26) 40 (62) 0.001
Rectal cancer 6 (30) 37 (54) 0.055
Lung cancer 8 (35) 43 (48) 0.264
Gastric cancer 9 (39) 43 (64) 0.023
Total cancer 40 (31) 198 (56) <0.01

AEG-1-Abs, anti-AEG-1 auto-antibodies.